PL2616550T3 - Sposób oddzielania cząsteczek lub cząstek docelowych z próbki zawierającej fibrynogen, w tym składniki krwi - Google Patents
Sposób oddzielania cząsteczek lub cząstek docelowych z próbki zawierającej fibrynogen, w tym składniki krwiInfo
- Publication number
- PL2616550T3 PL2616550T3 PL11788227T PL11788227T PL2616550T3 PL 2616550 T3 PL2616550 T3 PL 2616550T3 PL 11788227 T PL11788227 T PL 11788227T PL 11788227 T PL11788227 T PL 11788227T PL 2616550 T3 PL2616550 T3 PL 2616550T3
- Authority
- PL
- Poland
- Prior art keywords
- fibrinogen
- particles
- target molecules
- blood components
- including blood
- Prior art date
Links
- 102000008946 Fibrinogen Human genes 0.000 title 1
- 108010049003 Fibrinogen Proteins 0.000 title 1
- 239000012503 blood component Substances 0.000 title 1
- 229940012952 fibrinogen Drugs 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/14—Streptococcus; Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH14782010 | 2010-09-15 | ||
| CH20412010 | 2010-12-07 | ||
| CH12072011 | 2011-07-20 | ||
| PCT/IB2011/054035 WO2012035508A2 (en) | 2010-09-15 | 2011-09-15 | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
| EP11788227.4A EP2616550B1 (en) | 2010-09-15 | 2011-09-15 | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2616550T3 true PL2616550T3 (pl) | 2016-08-31 |
Family
ID=45044632
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16154770T PL3067431T3 (pl) | 2010-09-15 | 2011-09-15 | Urządzenie zawierające składniki krwi do oddzielania z próbek docelowych cząsteczek lub cząstek |
| PL11788227T PL2616550T3 (pl) | 2010-09-15 | 2011-09-15 | Sposób oddzielania cząsteczek lub cząstek docelowych z próbki zawierającej fibrynogen, w tym składniki krwi |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16154770T PL3067431T3 (pl) | 2010-09-15 | 2011-09-15 | Urządzenie zawierające składniki krwi do oddzielania z próbek docelowych cząsteczek lub cząstek |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US9689881B2 (pl) |
| EP (2) | EP2616550B1 (pl) |
| JP (1) | JP5999776B2 (pl) |
| KR (1) | KR101948944B1 (pl) |
| CN (2) | CN103108959B (pl) |
| AU (2) | AU2011303467C1 (pl) |
| CA (1) | CA2811493C (pl) |
| CY (1) | CY1122166T1 (pl) |
| DK (2) | DK3067431T3 (pl) |
| ES (2) | ES2751660T3 (pl) |
| HR (1) | HRP20191785T1 (pl) |
| HU (2) | HUE045771T2 (pl) |
| LT (1) | LT3067431T (pl) |
| PL (2) | PL3067431T3 (pl) |
| PT (1) | PT3067431T (pl) |
| SI (1) | SI3067431T1 (pl) |
| WO (1) | WO2012035508A2 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2811493C (en) | 2010-09-15 | 2020-06-16 | Debiopharm International Sa | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
| WO2013003356A1 (en) | 2011-06-27 | 2013-01-03 | Emory University | Compositions, uses, and preparation of platelet lysates |
| WO2014160796A1 (en) * | 2013-03-29 | 2014-10-02 | Siemens Healthcare Diagnostics Inc. | Rare cell concentration |
| HRP20191225T1 (hr) | 2014-06-01 | 2019-10-18 | Debiopharm International Sa | Uređaj za prikupljanje uzoraka i preradu |
| EP3383547A4 (en) | 2015-11-30 | 2019-08-07 | DH Technologies Development PTE. Ltd. | ELECTROMAGNETIC MODULES FOR PROCESSING FLUIDS |
| US10596236B2 (en) | 2016-03-10 | 2020-03-24 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
| AU2017230810B2 (en) | 2016-03-10 | 2022-03-10 | Arthrex, Inc. | Systems and methods for preparing protein enhanced serums |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| JP7298449B2 (ja) * | 2019-11-14 | 2023-06-27 | 株式会社島津製作所 | 血液凝固分析装置、及び分注ノズルの洗浄方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1035260A (en) * | 1974-08-12 | 1978-07-25 | Baxter Travenol Laboratories | Collection and processing tube |
| FR2625321B1 (fr) * | 1987-12-24 | 1992-10-02 | Pasteur Institut | Reactif pour le diagnostic de staphylococcus aureus par agglutination |
| DE3803463A1 (de) * | 1988-02-05 | 1989-08-17 | Linhart Axel | Semiquantitativer kalzium-schnelltest |
| DE58902472D1 (de) * | 1988-01-05 | 1992-11-26 | Linhart Axel | Verfahren und test-kit zur semiquantitativen bestimmung des kalziumgehaltes im blut. |
| US5691160A (en) * | 1992-08-14 | 1997-11-25 | Biogen, Inc. | Effects of actin filaments of fibrin clot structure and lysis |
| EP0587398B1 (en) * | 1992-09-09 | 1998-01-14 | Tokuyama Corporation | Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof |
| JP3292760B2 (ja) * | 1993-04-22 | 2002-06-17 | テルモ株式会社 | 採血管およびその製造方法 |
| US5670329A (en) * | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
| CA2176810A1 (en) | 1993-12-03 | 1995-06-08 | Gordon L. Dorn | Method for improving quantitative recovery of microorganisms from speci mens containing blood components |
| DE19602673A1 (de) * | 1996-01-25 | 1997-08-07 | Pereg Gmbh | Synthetische Testanschmutzung |
| US6121232A (en) * | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| US6680195B1 (en) * | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| JP2000262499A (ja) * | 2000-01-01 | 2000-09-26 | Terumo Corp | 採血管 |
| US6686204B2 (en) * | 2001-08-27 | 2004-02-03 | Becton, Dickinson & Company | Collection device |
| CN1606447A (zh) * | 2001-10-03 | 2005-04-13 | 克里斯托弗·J·伍尔弗顿 | 保存稳定的纤维蛋白原溶液 |
| CA2484554C (en) * | 2002-05-01 | 2012-12-04 | Synapse B.V. | Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media |
| ATE335816T1 (de) | 2002-09-18 | 2006-09-15 | Sirs Lab Gmbh | Verfahren zum nachweis prokaryontischer dna |
| PT2103694E (pt) * | 2003-08-15 | 2011-07-26 | Univ South Florida | Materiais e métodos para a captura de patogénios e a remoção de ácido aurintricarboxílico de uma amostra |
| US20050065454A1 (en) * | 2003-09-22 | 2005-03-24 | Becton, Dickinson And Company | Non-evacuated blood collection tube |
| US7399609B2 (en) * | 2003-12-30 | 2008-07-15 | 3M Innovative Properties Company | Staphylococcus detection |
| US8419722B2 (en) * | 2004-10-29 | 2013-04-16 | Spinal Restoration, Inc. | Apparatus and method for injection of fibrin sealant in spinal applications |
| DE102005009479A1 (de) | 2005-03-02 | 2006-09-07 | Molzym Gmbh & Co. Kg | Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden |
| JP2009502166A (ja) * | 2005-07-29 | 2009-01-29 | エコール ポリテクニーク フェデラル ドゥ ローザンヌ | 分子改変体フィブリノゲン融合タンパク質 |
| US20080299587A1 (en) * | 2007-05-03 | 2008-12-04 | Dennis Durbin | Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists |
| US8481265B2 (en) | 2007-08-02 | 2013-07-09 | Universite Laval | Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids |
| JP5029217B2 (ja) * | 2007-08-27 | 2012-09-19 | 東レ株式会社 | シート状物の製造方法 |
| AU2009268052B2 (en) * | 2008-07-09 | 2015-05-28 | Mallinckrodt Pharma Ip Trading D.A.C. | Recombinant fibrinogen |
| AU2010272505B2 (en) | 2009-07-16 | 2015-09-17 | Glaxosmithkline Biologicals S.A. | Treatment of infections |
| CA2811493C (en) | 2010-09-15 | 2020-06-16 | Debiopharm International Sa | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
-
2011
- 2011-09-15 CA CA2811493A patent/CA2811493C/en active Active
- 2011-09-15 PT PT161547708T patent/PT3067431T/pt unknown
- 2011-09-15 LT LT16154770T patent/LT3067431T/lt unknown
- 2011-09-15 SI SI201131797T patent/SI3067431T1/sl unknown
- 2011-09-15 DK DK16154770.8T patent/DK3067431T3/da active
- 2011-09-15 US US13/822,209 patent/US9689881B2/en active Active
- 2011-09-15 EP EP11788227.4A patent/EP2616550B1/en active Active
- 2011-09-15 AU AU2011303467A patent/AU2011303467C1/en not_active Ceased
- 2011-09-15 PL PL16154770T patent/PL3067431T3/pl unknown
- 2011-09-15 DK DK11788227.4T patent/DK2616550T3/en active
- 2011-09-15 EP EP16154770.8A patent/EP3067431B1/en active Active
- 2011-09-15 ES ES16154770T patent/ES2751660T3/es active Active
- 2011-09-15 CN CN201180044211.XA patent/CN103108959B/zh active Active
- 2011-09-15 WO PCT/IB2011/054035 patent/WO2012035508A2/en not_active Ceased
- 2011-09-15 ES ES11788227T patent/ES2571127T3/es active Active
- 2011-09-15 KR KR1020137009329A patent/KR101948944B1/ko active Active
- 2011-09-15 JP JP2013528815A patent/JP5999776B2/ja active Active
- 2011-09-15 HU HUE16154770A patent/HUE045771T2/hu unknown
- 2011-09-15 CN CN201710338814.XA patent/CN107389932B/zh active Active
- 2011-09-15 HU HUE11788227A patent/HUE028915T2/en unknown
- 2011-09-15 PL PL11788227T patent/PL2616550T3/pl unknown
-
2016
- 2016-12-02 AU AU2016266066A patent/AU2016266066B2/en not_active Ceased
-
2017
- 2017-05-22 US US15/601,677 patent/US20170336424A1/en not_active Abandoned
-
2019
- 2019-10-02 HR HRP20191785TT patent/HRP20191785T1/hr unknown
- 2019-10-11 CY CY20191101074T patent/CY1122166T1/el unknown
-
2021
- 2021-01-28 US US17/160,814 patent/US20210148940A1/en not_active Abandoned
-
2023
- 2023-08-09 US US18/231,880 patent/US20240280593A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3067431T (pt) | Dispositivo incluindo componentes sanguíneos para separação de moléculas ou partículas alvo a partir de amostras | |
| SG11201406727QA (en) | Apparatus and method for separating a biological entity from a sample volume | |
| SG10201601174XA (en) | Automated System For Sample Preparation And Analysis | |
| EP2649447A4 (en) | Sample analysis system | |
| IL223853A (en) | A method for analyzing biological findings using spectral imaging | |
| EP2462157A4 (en) | PROCESS FOR CLEANING A TARGET PROTEIN OF ONE OR MORE CONTAMINANTS IN A SAMPLE | |
| SG11201401913YA (en) | Systems and methods for biological analysis | |
| GB201111357D0 (en) | Method and apparatus for identification of samples field of the invention | |
| EP2588947A4 (en) | METHOD AND APPARATUS FOR TARGET INTERACTION AND PREDICTION BASED ON MOVEMENT | |
| EP2625502A4 (en) | METHODS AND SYSTEMS FOR EFFICIENT TREATMENT OF BIOLOGICAL SAMPLES | |
| SG11201406039WA (en) | Systems and methods for containing biological samples | |
| PL2895855T3 (pl) | Układ i sposób eluowania i badania substancji z próbki wydychanego aerozolu | |
| FI20106079A7 (fi) | Menetelmä epäpuhtauksien erottamiseksi nesteistä tai höyryistä | |
| EP2663403A1 (en) | Device and method for purifying air from non-desired components and for eliminating such components | |
| SG11201401911XA (en) | Systems and methods for biological analysis | |
| EP2711421A4 (en) | METHOD OF SEPARATING AND PURIFYING RNA FROM BIOLOGICAL MATERIAL | |
| IT1401316B1 (it) | Filtro perfezionato per la rimozione di sostanze dal sangue o da emoderivati e metodo per il suo ottenimento | |
| EP2615452A4 (en) | PROCESS FOR SEPARATING BIOLOGICAL SOLUBLE MATERIAL IN WATER | |
| GB2477189B (en) | System & method for determining blood component concentration | |
| EP2554998A4 (en) | Sample analysis system | |
| EP2418933A4 (en) | Sensing techniques for on-farm analysis of milk components | |
| PL2598888T3 (pl) | Metoda analityczna dla cząsteczek Fab i Fab' | |
| AT506495A3 (de) | Vorrichtung zur trennung von teilbahnen | |
| IL230736A0 (en) | A method for pretreatment of a biological sample that includes protein | |
| GB201018377D0 (en) | Method for the analysis of a biological sample of a patient |